Ayal Ronen

Vice President, FreeMind Group

We are witnessing a continuous movement by the NIH and DOD towards the life science industry, with a greater understanding as to the industry's needs, focus, and challenges. The scope of funding support given to industry R&D efforts from non-dilutive sources such as NIH and DOD covers the entire R&D cycle from early stage exploratory activities and all the way to late stage clinical research activities (Phase I, and II).

All non-dilutive sources are now expressing greater than ever interest in the R&D efforts of the industry, and more so in the unique set of skills and assets presented by collaborative academia-industry alliances. In the presentation we will discuss the latest trends at the NIH and DOD and the new available large scale and clinical stage funding opportunities.

In addition we will discuss:

•  Large scale funding opportunities
• The challenges in putting together a complex and large scale application
• Process for applying, requirements and limitations
• How to maximize chances for success
• Industry & academia collaboration
• Government funding as a strategic source of funding